AI-generated summary
The authors report a randomized trial of 24 adults with implant-related inferior alveolar nerve paresthesia, comparing eight sessions of 810-nm diode laser therapy with an inactive laser sham. Sensory tests showed greater reductions in paresthesia scores in the laser group than in the control group at follow-up, with no adverse events reported. The study was small, so the findings are preliminary.
- Participants
- 24
- Who or what was studied
- Adults with recent implant-related inferior alveolar nerve paresthesia (mean age 51 years, plus or minus 7)
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The trial was small with 24 participants, and the abstract does not describe longer-term follow-up beyond four weeks after the final session.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Photobiomodulation (PBM) has shown promise for managing nerve paraesthesia. This trial assessed the efficacy of an 810-nm diode laser on deep-mechanical, superficial-mechanical and thermal sensitivity for inferior alveolar nerve paresthesia after implant surgery.
Material And Methods
Twenty-four adults with recent implant-related paraesthesia were randomly assigned, in a parallel design, to an intervention or control group; both groups received routine vitamin-B supplementation. The intervention group underwent eight diode-laser sessions (200 mW power and 6 J/cm2 energy density) over four weeks, directed at peri-implant mucosa and adjacent cheek skin. The control group attended identical sessions with an inactive laser. Blinded examiners recorded visual-analogue-scale (VAS) scores for the Clamp (deep mechanical), Swab (light mechanical) and Ice (thermal) tests at baseline and at two and four weeks after the final session. Data were analysed with the Shapiro-Wilk test, independent-samples t-test and Friedman test (α=0.05).
Results
All twenty-four randomised participants (mean age 51±7 years) completed follow-up. Baseline VAS scores did not differ between groups (p>0.44). Although both groups improved over time, the VAS scores for paresthesia reductions in the PBM group were significantly greater than those in the control group at both follow-ups for all three tests (all p<0.001). No adverse events were reported.
Conclusions
Eight sessions of 810-nm PBM produced faster and more pronounced sensory recovery than sham treatment in patients with implant-related paraesthesia.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 6 J/cm2
- Power
- 200 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Visual analogue scale, Control group, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.